Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT01206218
Eligibility Criteria:
Inclusion Criteria:
* Provision of informed consent
* Female or male aged 18 years and over
* Histologic or cytologic confirmation of advanced gastric cancer
* Stage III-IV (AJCC 7th)
* ECOG: 0-2
* Have tumor sample that can be tested for BRCA1 mRNA expression
* Negative pregnancy test for women of childbearing potential
* Neutrophile granulocyte greater than 1.5×10\^9/L
* Hemoglobin greater than 10g/dL
* Platelet greater than 100×10\^9/L
* Serum bilirubin not greater than 1.5x upper limit of reference range (ULRR)
* ALT or AST not greater than 1.5x ULRR
* Creatinine clearance no less than 60ml/min
Exclusion Criteria:
* Have at least another primary malignant tumor
* Active infection
* Chemotherapy with experimental drug within 3 weeks before the start of study therapy
* Women who are pregnant or breast feeding
* Weight loss greater 10% within 6 weeks before the start of study therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01206218
Study Brief:
Protocol Section:
NCT01206218